Trump signs healthcare executive order that includes a win for pharma companies | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
June 11, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JUNE 11, 2025
Trump signs healthcare executive order that includes a win for pharma companies

USA

Reuters
16 April, 2025, 11:55 am
Last modified: 16 April, 2025, 03:26 pm

Related News

  • Chinese consumer prices continue to fall as US trade talks loom
  • Trump's travel ban on 12 countries goes into effect
  • Key US-China trade talks set for Monday in London
  • Los Angeles police order protesters in downtown to go home
  • Trump says Musk relationship over, warns of 'serious consequences' if he funds Democrats

Trump signs healthcare executive order that includes a win for pharma companies

Drugmakers have been pushing to delay the timeline under which medications become eligible for price negotiations by four years for small molecule drugs, which are primarily pills and account for most medicines

Reuters
16 April, 2025, 11:55 am
Last modified: 16 April, 2025, 03:26 pm
US President Donald Trump reacts as he meets NATO Secretary General Mark Rutte (not pictured), in the Oval Office at the White House in Washington, DC, US, March 13, 2025. Photo: REUTERS/Evelyn Hockstein/File Photo
US President Donald Trump reacts as he meets NATO Secretary General Mark Rutte (not pictured), in the Oval Office at the White House in Washington, DC, US, March 13, 2025. Photo: REUTERS/Evelyn Hockstein/File Photo

Highlights:

  • Trump's order targets Medicare drug price negotiation timeline
  • Congress must approve changes to Medicare price negotiations
  • Order encourages state drug importation programs
  • FDA urged to streamline approval for generics and biosimilars

US President Donald Trump directed his health department on Tuesday to work with Congress on revamping a law that allows Medicare to negotiate prescription drug prices, seeking to introduce a change the pharmaceutical industry has lobbied for.

Drugmakers have been pushing to delay the timeline under which medications become eligible for price negotiations by four years for small molecule drugs, which are primarily pills and account for most medicines.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

That would align with the 13-year wait until more complex biotech drugs become eligible for Medicare price negotiations.

The wide-ranging executive order signed by Trump aims to reduce healthcare costs. It comes one day after the Trump administration instituted a national security report into the pharmaceutical industry, a precursor to sector-specific tariffs.

The ability of Medicare for the first time to directly negotiate prices on selected medicines was part of President Joe Biden's Inflation Reduction Act. Medicare covers 66 million Americans, mostly aged 65 and older.

Drugmakers have complained about the terms of Medicare's negotiating powers, saying it would stifle innovation. In particular, the industry has opposed the time frame for negotiation eligibility for most drugs.

When drugs have no competition, the law now allows the government to negotiate prices for complex biologic, or biotech, drugs after 13 years on the market, but after 9 years for drugs taken as pills and capsules.

Trump cannot implement the change through executive order because the negotiation process is outlined in legislation, but his order instructs Secretary of Health and Human Services Robert F. Kennedy Jr. to work with Congress on changing it.

Other proposed changes to the negotiation process would yield more savings than those achieved during the first round under the Biden administration, White House officials told reporters on a call before the signing without providing specifics.

Biden's administration had negotiated a price cut of as much as 79% for the first group of 10 drugs seen as among the most costly to the Medicare program.

The Trump administration will negotiate prices for the second group of 15 medications, which includes Novo Nordisk's blockbuster diabetes and weight-loss treatments Ozempic and Wegovy as well as Pfizer's cancer drugs Ibrance and Xtandi.

Trump's order also seeks to align Medicare payments for drugs with those of hospitals, which can be 35% lower, and calls for standardizing patient payment rates across locations so that people are not charged different rates depending on where they receive care, a policy known as site-neutral payments.

Trump directed the Food and Drug Administration to encourage more applications from states for drug importation programs, which were initiated during his first term.

So far only Florida has won FDA authorization to directly import drugs from Canada, even though several more states have applied. It also directs the FDA to streamline approval for less expensive generic and biosimilar versions of branded medicines.

Top News / World+Biz

Donald Trump / Trump Tariffs / Trump Trade War / Pharma industry

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Bangladesh's growth forecast unchanged: WB report
    Bangladesh's growth forecast unchanged: WB report
  • Faiz Ahmad Tayeb. Photo: BSS
    Import duty on raw materials for e-bikes, lithium batteries reduced from 80% to 1% in some cases: Faiz Taiyeb
  • Swedish activist Greta Thunberg, who departed Israel by plane on Tuesday after being detained aboard the Gaza-bound British-flagged yacht "Madleen" after Israeli forces boarded the charity vessel as it attempted to reach the Gaza Strip in defiance of an Israeli naval blockade, talks to journalists surrounded by French police as she arrives at a terminal at the Paris-Charles de Gaulle Airport, in Roissy-en-France near Paris, France, June 10, 2025. REUTERS/Gonzalo Fuentes
    Greta Thunberg says she was kidnapped by Israel in international waters

MOST VIEWED

  • On left, Abdullah Hil Rakib, former senior vice president (SVP) of BGMEA and additional managing director of Team Group; on right, Captain Md Saifuzzaman (Guddu), a Boeing 787 Dreamliner pilot for Biman Bangladesh Airlines. Photos: Collected
    Ex-BGMEA SVP Abdullah Hil Rakib, Biman 787 pilot Saifuzzaman drown in boating accident in Canada
  • File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar
    Dhaka: The city we never want to return to, but always do
  • Chief Adviser Muhammad Yunus leaves for a four-day visit to the United Kingdom from the Dhaka airport on 9 June 2025. Photo: CA Press Wing
    CA Yunus leaves for UK; discussion expected on renewable energy investment, laundered money
  • File Photo: Collected
    Enhanced surveillance at Ctg airport amid rising global Covid-19 cases
  • Inside the aid ship stormed by Israeli forces on 9 June 2025. Photo: BBC
    Israeli forces stormed aid boat carrying Greta Thunberg bound for Gaza: Freedom Flotilla Coalition
  • Photos: Collected
    Abdul Hamid wasn't arrested because he's not wanted right now: Home adviser

Related News

  • Chinese consumer prices continue to fall as US trade talks loom
  • Trump's travel ban on 12 countries goes into effect
  • Key US-China trade talks set for Monday in London
  • Los Angeles police order protesters in downtown to go home
  • Trump says Musk relationship over, warns of 'serious consequences' if he funds Democrats

Features

Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

7h | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

1d | Features
Photo collage shows political posters in Bagerhat. Photos: Jannatul Naym Pieal

From Sheikh Dynasty to sibling rivalry: Bagerhat signals a turning tide in local politics

3d | Bangladesh
Illustration: TBS

Unbearable weight of the white coat: The mental health crisis in our medical colleges

6d | Panorama

More Videos from TBS

Greta Thunberg deported from Israel

Greta Thunberg deported from Israel

9h | TBS World
BNP is not a revolutionary party: Mirza Fakhrul

BNP is not a revolutionary party: Mirza Fakhrul

10h | TBS Today
News of The Day, 10 JUNE 2025

News of The Day, 10 JUNE 2025

7h | TBS News of the day
Trump sends 2,000 more National Guard and 700 Marines to Los Angeles

Trump sends 2,000 more National Guard and 700 Marines to Los Angeles

10h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net